Kellie Charles

Kellie is the Head of Pharmacology in the Sydney Pharmacy School, University of Sydney. I have 20 years experience in conducting clinical trials of immunology drugs in cancer and also extensive experience in cellular and animal models of cancer and inflammation. I have a strong interest in new drug development for all medications used to treat cancer and immune system (including autoimmune, allergy, inflammation). I am a current Director on the Board of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT - national premier body for pharmacology research and education innovation).